176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
View analysts' price targets and recommendations, and compare them with competitors.
$207.00
Analysts expect the stock price to increase by 16.41%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
93.57B
Revenue has increased from the previous period.
53.59%
Revenue growth rate has decreased from the previous period.
35.20B
EBITDA has decreased from the previous period.
37.62%
EBITDA margin has decreased from the previous period.
30.96B
EBIT has decreased from the previous period.
33.09%
EBIT margin has decreased from the previous period.
4.24B
Depreciation has increased from the previous period.
63.61B
Total cash has increased from the previous period.
67.98%
Cash percentage has increased from the previous period.
14.53B
Receivables have increased from the previous period.
15.52%
Receivables percentage has decreased from the previous period.
10.74B
Inventories have increased from the previous period.
11.48%
Inventory percentage has increased from the previous period.
5.36B
Accounts payable has increased from the previous period.
5.73%
Payables percentage has increased from the previous period.
-4.38B
Capital expenditure has increased from the previous period.
-4.68%
CapEx percentage has increased from the previous period.
12.05%
WACC is unchanged from the previous period.
12.08%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.66
Beta is unchanged from the previous period.
24.94B
Diluted shares outstanding is unchanged from the previous period.
11.06B
Total debt is unchanged from the previous period.
3.35T
Total equity is unchanged from the previous period.
3.36T
Total capital is unchanged from the previous period.
0.33%
Debt weighting is unchanged from the previous period.
99.67%
Equity weighting is unchanged from the previous period.
29.63B
EBIAT has decreased from the previous period.
22.16B
UFCF has decreased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
1.62T
Terminal value is unchanged from the previous period.
1.12T
Enterprise value has decreased from the previous period.
3.78B
Net debt is unchanged from the previous period.
1.12T
Equity value has decreased from the previous period.
44.94
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
197.30B
The estimated revenue has increased from the previous period.
74.22B
The estimated EBITDA has increased from the previous period.
4.42
The estimated EPS has increased from the previous period.
104.26B
The estimated net income has increased from the previous period.
65.28B
The estimated EBIT has increased from the previous period.
17.01B
The estimated SG&A expenses have increased from the previous period.
